YUTHI
← All articles
Sport · Cycling

Cycling and health: what long-term studies actually show

3 Min. read YUTHI Redaktion

Regular cycling demonstrably lowers your risk of heart disease, cancer and premature death. UK Biobank and Copenhagen data show impressive effects — even for e-bike commuters.

What the UK Biobank says about cyclists

The UK Biobank is one of the largest health databases in the world: more than 500,000 participants, observed over many years. An analysis by Celis-Morales and colleagues (BMJ, 2017) examined how commuting affects health. The result for cyclists was clear: compared to people who commute by car, cycling commuters had a 41% lower risk of cardiovascular mortality and a 46% lower cancer risk.

Overall mortality also dropped: people who cycled to work had a 41% lower risk of dying than those who commuted exclusively by passive transport. These figures are associations, not causal proof — but the effect size is so consistent across different analyses that it is considered a robust signal.

The Copenhagen perspective

Denmark is one of the most cycling-intensive countries in the world, and the epidemiological data reflects that. Lars Bo Andersen and colleagues analysed data from the Copenhagen City Heart Study in 2000 and reached a similar finding: cycling commuters had roughly 28% lower overall mortality than non-cycling commuters — even after leisure activity was adjusted for. Cycling to work is therefore an independent protective factor, not simply a proxy for an overall more active lifestyle.

Particularly telling is how little cycling was needed to see effects: even one hour of cycling per week was associated with measurable health benefits. A low threshold that is realistic for many people.

Heart, metabolism, muscles: what cycling trains

Cycling is primarily an endurance sport and places similar demands on the cardiovascular system as running or swimming. Maximum oxygen uptake (VO₂max) can be significantly improved with regular cycling. At the same time, pedalling mainly activates the thigh and gluteal muscles — muscle groups that are closely linked to glucose metabolism and insulin sensitivity.

The advantage over running: joint stress on the knees and hips is considerably lower. Cycling is therefore particularly suitable for people returning to activity after a knee injury, or those who want to protect their joints without giving up cardiovascular training.

E-bikes: cheating or a sensible entry point?

E-bikes are controversial in the longevity community. The objection: the motor makes it easy, so the health benefit disappears. The research says otherwise. A Swiss study showed that e-bike commuters achieved similar cardiovascular improvements to conventional cyclists — because, despite the motor, they cycled more, rode further and chose the bike over the car more often.

For people who have previously been largely inactive, the e-bike is a low-barrier entry into regular physical activity. It also makes it possible to integrate cycling as everyday transport on hilly routes or long distances — which is more effective for health than occasional intensive training.

Cycling as a daily habit — track it with the YUTHI app

The biggest advantage of cycling is how easily it fits into everyday life: using your bike as transport means training without any extra effort. Three times a week for 20 minutes — for example on your commute — adds up to around 50 hours of active movement over a year.

In the YUTHI app you can log your cycling sessions and track them alongside other activities and health data. If you combine your commute with cycling, you'll see after a few weeks how resting heart rate, endurance and wellbeing develop — often faster than expected.

Continue in the app

That was the snapshot. The app turns it into daily support.

Measure every day instead of calculating once: Vito or Vita puts your numbers in context, builds you a weekly plan and speaks up when something stands out.

Soon on theApp Store Soon onGoogle Play

Launching at the end of 2026 — iPhone first, Android to follow. Let me know when it’s out ↓

Sources